Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection (2020)
- Authors:
- Autor USP: CASSEB, JORGE SIMÃO DO ROSÁRIO - FM
- Unidade: FM
- DOI: 10.1016/j.micpath.2020.104198
- Subjects: ARTRITE; DERMATITE; GENES; LINFOMA; SÍNDROME DE SJOGREN
- Language: Inglês
- Imprenta:
- Source:
- Título: Microbial pathogenesis
- ISSN: 0882-4010
- Volume/Número/Paginação/Ano: v. 144, article ID 104198, 8p, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
KEIKHA, Masoud et al. Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection. Microbial pathogenesis, v. 144, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.micpath.2020.104198. Acesso em: 13 jun. 2025. -
APA
Keikha, M., Ghazvini, K., Eslami, M., Yousefi, B., Casseb, J. S. do R., Yousefi, M., & Karbalaei, M. (2020). Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection. Microbial pathogenesis, 144. doi:10.1016/j.micpath.2020.104198 -
NLM
Keikha M, Ghazvini K, Eslami M, Yousefi B, Casseb JS do R, Yousefi M, Karbalaei M. Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection [Internet]. Microbial pathogenesis. 2020 ; 144[citado 2025 jun. 13 ] Available from: https://doi.org/10.1016/j.micpath.2020.104198 -
Vancouver
Keikha M, Ghazvini K, Eslami M, Yousefi B, Casseb JS do R, Yousefi M, Karbalaei M. Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection [Internet]. Microbial pathogenesis. 2020 ; 144[citado 2025 jun. 13 ] Available from: https://doi.org/10.1016/j.micpath.2020.104198 - Risk factors associated with HTLV-1 vertical transmission in Brazil: longer breastfeeding, higher maternal proviral load and previous HTLV-1-infected offspring
- Cognitive impairment is frequent among symptomatic carriers of human T-cell lymphotropic virus type 1 (HTLV-1), regardless of their clinical status
- Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients
- Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial
- Origin and prevalence of human T-lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) among indigenous populations in the Americas
- Manifestações dermatológicas na síndrome da imunodeficiência adquirida
- Adult T-cell leukaemia/lymphoma in Brazil [Carta]: a rare disease or rarely diagnosed?
- Health state utility values in people living with HTLV-1 and in patients with HAM/TSP: the impact of a neglected disease on the quality of life
- In vitro basal T-cell proliferation among asymptomatic Human T cell Leukemia Virus type 1 patients co-infected with hepatitis C and/or Human Immunodeficiency Virus type 1
- Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects
Informações sobre o DOI: 10.1016/j.micpath.2020.104198 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
